Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-22 @ 9:14 AM
Study NCT ID:
NCT04560751
Status:
UNKNOWN
Last Update Posted:
2020-09-23
First Post:
2020-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)
Sponsor:
Zhejiang Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-10
First Submit QC Date:
None
Study First Post Date:
2020-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-22
Last Update Post Date:
2020-09-23
Last Update Post Date Type:
ACTUAL